Lipella Pharmaceuticals Inc. Proceeds from Notes Payable
Lipella Pharmaceuticals Inc. (LIPO) reported Proceeds from Notes Payable of $25.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-02-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2024-02-27
- Lipella Pharmaceuticals Inc. proceeds from notes payable for fiscal 2022 was $25.00K.
| Period end | Proceeds from Notes Payable 12 month |
|---|---|
| 2022-12-31 | $25.00K 10-K · filed 2024-02-27 |